MedTrace Logo

Thromboprophylaxis by Low Molecular Heparin During the Post-partum Period

NCT04883385 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-09-15

No results posted yet for this study

Summary

The purpose of this study is to determine the current level of adequacy of the thromboprophylaxis prescriptions with the specific institutional protocol during the post-partum period. The institutional protocol is based on national and international guidelines.

Conditions

  • Thromboembolic Disease

Interventions

OTHER

medical data collection

collection of medical data from patients' medical records

Sponsors & Collaborators

  • Centre Hospitalier Sud Francilien

    lead OTHER

Principal Investigators

  • Elsa BROCAS, MD · Centre Hospitalier Sud Francilien

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-08
Primary Completion
2022-07-09
Completion
2022-07-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04883385 on ClinicalTrials.gov